VMD

In the past six months, Viemed Healthcare, Inc. reported record Q2 2026 net revenue of $78.1 million, a 23.9% year-over-year increase, and Q1 2026 net revenue of $75.4 million, up 28% year-over-year. Net income attributable to Viemed was $2.8 million in Q2 2026 and $2.6 million in Q1 2026. The company also announced a 2026 share repurchase program, authorizing purchases of up to 1,930,131 common shares, approximately 5% of issued shares. Additionally, on September 24, 2026, President Michael Moore adopted an automatic securities disposition plan, permitting sales of up to 246,000 common shares held by an entity he controls. The stock price as of September 30, 2026, was $9.09 per share, representing a 31.17% increase from October 1, 2025. The stock has traded in a 52-week range between $6.05 and $12.61. Following its Q2 2026 earnings announcement on August 3, 2026, VMD shares declined by 15.9% the next day.